EODData

MEMBERSHIP REGISTER LOG IN

FRA, RGN: Repligen Corporation

14 Jan 2026
LAST:

140.1

CHANGE:
 2.70		OPEN:
141.8		HIGH:
141.8		ASK:
0.0		VOLUME:
100
CHG(%):
1.89		PREV:
142.8		LOW:
140.1		BID:
0.0		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
14 Jan 26141.8141.8140.1140.1100
13 Jan 26142.8142.8142.8142.835
12 Jan 26139.9139.9139.9139.935
09 Jan 26141.4141.4141.4141.435
08 Jan 26142.8142.8142.8142.835
07 Jan 26145.8145.8145.8145.835
06 Jan 26142.9142.9142.9142.935
05 Jan 26139.3139.3139.3139.335
02 Jan 26138.0138.0138.0138.035
30 Dec 25139.2139.2139.2139.235

PROFILE

Name:Repligen Corporation
About:Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Sector:Healthcare
Industry:Medical Instruments & Supplies
Address:Building 1, Waltham, MA, United States, 02453
Website:https://www.repligen.com
ISIN:US7599161095
LEI:54930006QJ0T5AUO1E71

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:13,900.00 
Forward P/E:46.03 
PEG Ratio:46.03 
Price to Sales:11.54 
Price to Book:4.43 
Profit Margin:0.00 
Operating Margin:0.07 
Return on Assets:0.01 
Return on Equity:0.00 
Revenue:601.35M 
EBITDA:40.45M 
Shares:56.26M 
Market Cap:7.882B 

TECHNICAL INDICATORS

MA5:141.380.9%
MA10:141.210.8%
MA20:138.351.3%
MA50:136.182.9%
MA100:123.7213.2%
MA200:116.3920.4%
STO9:26.92
STO14:56.49
RSI14:64.05 
WPR14:-43.51
MTM14:7.40
ROC14:0.06 
ATR:2.05 
Week High:145.804.1%
Week Low:139.850.2%
Month High:145.804.1%
Month Low:132.0520.4%
Year High:168.8920.5%
Year Low:93.8249.3%
Volatility:16.68